In autoimmune hemolytic anemia, what typically happens to red blood cells?

Prepare for the RRD-3 Mechanisms of Defense: Inflammation and Immune Function Test. Utilize flashcards and multiple choice questions, complete with explanations and hints, to ace your exam!

Multiple Choice

In autoimmune hemolytic anemia, what typically happens to red blood cells?

Explanation:
In autoimmune hemolytic anemia, the primary issue is that the body's immune system mistakenly identifies its own red blood cells as foreign and mounts an attack against them. This leads to the destruction of red blood cells at an accelerated rate. The immune response can involve the production of antibodies that bind to the surface of red blood cells, marking them for destruction, primarily by macrophages in the spleen and liver. As a result, there is an overall decrease in the number of functional red blood cells, leading to the symptoms associated with anemia, such as fatigue and pallor. This accelerated destruction underscores the nature of the disorder, differentiating it from other processes that may involve red blood cell production or resilience. In contrast, the other options do not accurately describe the pathology of autoimmune hemolytic anemia. The red blood cells are not becoming resistant to damage, nor are they proliferating excessively. Similarly, the rate of production is not the central issue; rather, it is their premature destruction that defines the condition.

In autoimmune hemolytic anemia, the primary issue is that the body's immune system mistakenly identifies its own red blood cells as foreign and mounts an attack against them. This leads to the destruction of red blood cells at an accelerated rate. The immune response can involve the production of antibodies that bind to the surface of red blood cells, marking them for destruction, primarily by macrophages in the spleen and liver.

As a result, there is an overall decrease in the number of functional red blood cells, leading to the symptoms associated with anemia, such as fatigue and pallor. This accelerated destruction underscores the nature of the disorder, differentiating it from other processes that may involve red blood cell production or resilience.

In contrast, the other options do not accurately describe the pathology of autoimmune hemolytic anemia. The red blood cells are not becoming resistant to damage, nor are they proliferating excessively. Similarly, the rate of production is not the central issue; rather, it is their premature destruction that defines the condition.

Subscribe

Get the latest from Passetra

You can unsubscribe at any time. Read our privacy policy